Cargando…
Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
Lung cancer has been the most common cancer worldwide for several decades. The outcomes of patients with locally advanced lung cancer remain dismal, and only a minority of patients survive more than 5 years. However, tumor therapeutic resistance mechanisms are poorly studied. Identification of thera...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203496/ https://www.ncbi.nlm.nih.gov/pubmed/35710591 http://dx.doi.org/10.1038/s41598-022-14448-8 |